Benzinga's Top Upgrades

Analysts at Credit Suisse upgraded Enterprise Products Partners LP

from “neutral” to “outperform.” The target price for Enterprise Products Partners has been raised from $71 to $78. Enterprise Products Partners' shares closed at $68.80 yesterday. Analysts at Barclays upgraded Gannett Co

from “underweight” to “equal-weight.” The price target for Gannett has been raised from $24 to $25. Gannett's shares closed at $28.18 yesterday. Goldman Sachs upgraded Teva Pharmaceutical Industries

from “sell” to “neutral.” The price target for Teva Pharmaceutical has been raised from $40 to $52. Teva's shares closed at $49.91 yesterday. Analysts at Keefe Bruyette & Woods downgraded Walker & Dunlop

from “outperform” to “market perform.” The target price for Walker & Dunlop has been raised from $16 to $18. Walker & Dunlop's shares closed at $16.88 yesterday.